As the nation gears up for a massive vaccination effort, the Trump administration is doubling down on a novel, unproven injection device by providing more than half a billion dollars in government financing for something that is still awaiting FDA approval.
Trending:
As vaccine approvals loom, U.S. funds a back-up plan for delivery